Overview
- 76 inspections across 67 sites are on record.
- 86 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-08-27.
At a glance
Inspections
76
Sites
67
Observations
86
Career since
May 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Melinta Therapeutics, LLC. | 27 Aug 2021 | Human Drugs | |
| Insmed Incorporated | 3 Aug 2021 | Human Drugs | View 483 → |
| Novartis Pharmaceuticals Corporation | 9 Jul 2021 | Human Drugs | |
| Steven J. Glass, M.D. | 3 Jun 2021 | Human Drugs | |
| Roberta R. Ball, D.O. | 26 May 2021 | Human Drugs |
Sites inspected
Melinta Therapeutics, LLC.Morristown, United States1 insp.
Insmed IncorporatedBridgewater, United States1 insp.
Novartis Pharmaceuticals CorporationEast Hanover, United States1 insp.
Steven J. Glass, M.D.Berlin, United States1 insp.
Roberta R. Ball, D.O.Berlin, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Shirley S Wen11 shared
Peter R Lenahan9 shared
Michael Serrano7 shared
Jean M Mulinde2 shared
Anastasia I Offordile2 shared
Kelly N Kerr1 shared
Cheryl A Grandinetti1 shared
Byungja E Marciante1 shared
Xiaohan Cai1 shared
Lauren C Iacono-Connors1 shared
Full investigator report
Get the verbatim findings behind Nina Yang's 86 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site